18 eredmény a kulcsszóra: 'triple negative breast cancer'
The prepared copper(II) complexes and their metal-free ligands revealed antiproliferative activity against highly resistant cancer cell lines, including triple negative breast
N/A
10.3390/cancers13225694/s1, Table S1: Summary of reported cases of acinic cell carcinomas (ACC) without consideration of the grade or purity, Table S2: Literature review of
N/A
Conclusions: High stromal content was related to better survival in ER-positive breast cancers across both genders, contrasting data in triple-negative breast cancer and
N/A
oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer.. The triple negative paradox:
N/A
Complete Clinical Remission of Stage IV Triple-Negative Breast Cancer Lung Metastasis Administering Low-Dose Immune Checkpoint Blockade in Combination With Hyperthermia
N/A
Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study. Adams S, Loi S, Toppmeyer D
N/A
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes. Pala EE, Bayol Ü, Cumurcu S, et al. Immunohistochemical characteristics of triple
N/A
The MCF-7 cell line was used as a representative model for estrogen receptor (ER)-positive breast cancer, while the MDA-MB-231 cell line was used as a model of triple-negative
N/A
In this study, we aimed to characterize the role of capsaicin- sensitive fi bers in a mouse model of an orthotopically implanted, triple negative 4T1 breast cancer model,
N/A
Emens L, Braiteh F, Cassier P et al (2015) Inhibition of PD-L1 by MPDL3280A leads to clinical activity in patients with metastatic triple-negative breast cancer (TNBC). Schmid P,
N/A
Our aim was to study female-derived human H1975 lung and MDA-MB-231 triple-negative breast cancer ade- nocarcinoma cell line models using single cell mass cytom- etry.. Nine
N/A
The cytotoxicity assays of selected com- pounds (1–5, 7 and 9–11) on tumorigenic 4 T1 mouse triple negative breast cancer and non-tumorigenic D3 human brain endothelial cells
N/A
Swisher SK, Wu Y, Castaneda CA, Lyons GR, Yang F, Tapia C et al (2016) Interobserver agreement between pathologists assess- ing tumor-infiltrating lymphocytes (TILs) in breast
N/A
2.4Are there any differences in overall diagnostic score, mammography, breast density, radiomorphology, ultrasound, palpation and cytology results of the triple negative and the
N/A
Ezeket (az alkalmazhatóság statisztikai módszerekkel történő vizsgálata után) használhatjuk a gazdasági szerkezet átalakulásának nyomon követésére, ugyanakkor ebben az
N/A
tis in early breast cancer patients: effects of systemic treatments. és mtsai: Conformal adjuvant radiotherapy in breast cancer. és mtsa: Specialisation and breast
N/A
Central European Cooperative Oncology Group (2013) Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast
N/A